EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtMetaanalyseOpen Access

Impact of Isotretinoin Therapy on Thyroid Hormone Levels in Patients with Acne Vulgaris: A Systematic Review and Meta-Analysis

Mishari Tariq Alrubaiaan, Ajlan Hashim Alajlani, Raneem Alwatban, Abdulelah Nabil Alkadi, Hawra Fahad Alkhodairy, Fatimah Moayed Alalwan, Sarah Waleed Bin Rashid, Waleed Alajroush

Dermatology Practical & Conceptual · 31.07.2026 · 16 (3) · 7403

DOI: 10.5826/dpc.1603a7403 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Dermatology Practical & Conceptual, online erschienen am 31.07.2026. Verfasst von Mishari Tariq Alrubaiaan und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Systemic isotretinoin is extensively used to treat moderate-to-severe acne vulgaris and may have systemic endocrine effects through the hypothalamic-pituitary-thyroid axis.

Objectives

To investigate the changes in thyroid hormone levels after commencement of systemic isotretinoin among patients with acne vulgaris.

Methods

A PubMed, ScienceDirect, Scopus, and Cochrane Library search was performed. Pooled analysis was conducted utilizing Review Manager (RevMan 5.4.1).

Results

A total of 447 patients from eight observational studies were included. After three and four months, no increase in TSH levels was observed following isotretinoin treatment with a standardized mean difference (SMD) of 0.09 (95% CI: -0.27–0.46; P=0.62) and (SMD=0.72; 95% CI: -0.01–1.45; P>0.05), respectively. However, a significant increase in TSH levels was observed at six months (SMD=0.54; 95% CI: 0.05–1.03; P=0.03). T4 levels showed no alteration at three months (SMD= −0.24; 95% CI: -0.56–0.08; P=0.14) but were reduced at four months (SMD= -0.79; 95% CI: -1.20– -0.38; P=0.0001) and six months (SMD= -0.87; 95% CI: -1.57– -0.17; P=0.01). T3 levels were reduced at three months (SMD= -0.42; 95% CI: -0.80– -0.04; P=0.03), four months (SMD= -0.63; 95% CI: -1.03– -0.23; P=0.002), and 6 months (SMD= -1.13; 95% CI: -1.77– -0.55; P=0.0001).

Conclusion

Long-term isotretinoin treatment may cause time-dependent changes in thyroid hormone levels.

Autor:innen und Institutionen

  • College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • College of Medicine, King Faisal University, Al-Ahsa, Saudi Arabia.
  • College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Department of Pediatric Dermatology, King Abdulaziz Medical City, Riyadh, Saudi Arabia.

Zitieren

APA

Alrubaiaan, M. T., Alajlani, A. H., Alwatban, R., Alkadi, A. N., Alkhodairy, H. F., Alalwan, F. M., Rashid, S. W. B., & Alajroush, W. (2026). Impact of Isotretinoin Therapy on Thyroid Hormone Levels in Patients with Acne Vulgaris: A Systematic Review and Meta-Analysis. Dermatology Practical & Conceptual, 16(3), 7403. https://doi.org/10.5826/dpc.1603a7403

Vancouver

Alrubaiaan MT, Alajlani AH, Alwatban R, Alkadi AN, Alkhodairy HF, Alalwan FM, et al. Impact of Isotretinoin Therapy on Thyroid Hormone Levels in Patients with Acne Vulgaris: A Systematic Review and Meta-Analysis. Dermatology Practical & Conceptual. 2026;16(3):7403. doi:10.5826/dpc.1603a7403

BibTeX
@article{Alrubaiaan2026,
  author = {Alrubaiaan, Mishari Tariq and Alajlani, Ajlan Hashim and Alwatban, Raneem and Alkadi, Abdulelah Nabil and Alkhodairy, Hawra Fahad and Alalwan, Fatimah Moayed and Rashid, Sarah Waleed Bin and Alajroush, Waleed},
  title = {Impact of Isotretinoin Therapy on Thyroid Hormone Levels in Patients with Acne Vulgaris: A Systematic Review and Meta-Analysis},
  journal = {Dermatology Practical & Conceptual},
  year = {2026},
  volume = {16},
  number = {3},
  pages = {7403},
  doi = {10.5826/dpc.1603a7403}
}
Kostenlos starten →